Home Theolytics

Theolytics

In operation
-
Developer of New Anti-Cancer Biologics
Basic
Enterprise Profile

Basic Information

Theolytics is a biotechnology company that uses viruses to fight cancer.Theolytics' phenotypic screening platform is a step-change in the field of oncolytic virus therapy, capable of discovering and developing effective, targeted candidate drugs optimized for intravenous delivery and specific patient populations.In addition to advancing internal program projects covering solid tumors and liquid tumors, we have also established selected strategic partnerships to expand and accelerate the development of our programs.
Theolytics, Ltd.
Oxford,England,United Kingdom
15~50 people
January 01, 2017
enquiries@theolytics.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Biologics Innovative Drugs